• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU
Click for more information
1.43% 6.9¢

IMUGENE LIMITED

Market Cap $512.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMU
Why IMU is a multi multi bagger
393 394 395
13:46 23K 11M
13:46 Last post  rolly777 Comments Created with Sketch.  23K  Views Created with Sketch.  11M 
IMU
Rubbing my ball
27 28 29
26/05/24 1.6K 950K
26/05/24 Last post  Kombumerri Comments Created with Sketch.  1.6K  Views Created with Sketch.  950K 
IMU
IMUGENE CHART. TA only
542 543 544
26/05/24 32K 15M
TRENDING NEWS

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Read More   right-arrow Created with Sketch.
NEWS
27 May 2024
26/05/24 Last post  wednesdayschild Comments Created with Sketch.  32K  Views Created with Sketch.  15M 
IMU
Media Thread
230 231 232
23/05/24 13K 6.5M
23/05/24 Last post  AK78 Comments Created with Sketch.  13K  Views Created with Sketch.  6.5M 
IMU
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
2 3
22/05/24 163 70K
22/05/24 Last post  agrisorb Comments Created with Sketch.  163  Views Created with Sketch.  70K 
IMU
From the Professor...
2 3
21/05/24 178 78K
21/05/24 Last post  smart spider Comments Created with Sketch.  178  Views Created with Sketch.  78K 
IMU
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
2
20/05/24 119 48K
20/05/24 Last post  Duku Comments Created with Sketch.  119  Views Created with Sketch.  48K 
IMU
Lets compare - IMU 		19/05/24 1 992
19/05/24 Last post  BirdDog66 Comments Created with Sketch.  1  Views Created with Sketch.  992 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - IMU
06 May 16:10
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:48
 
Change of Director's Interest Notice - PH
23 Apr 16:50
 
Notification regarding unquoted securities - IMU
19 Apr 16:27
 
Imugene & Kincell Bio Strategic Partnership Investor Webinar
17 Apr 10:31
 
Imugene and Kincell Bio Announce Strategic Partnership
16 Apr 08:34
 
View More arrow Created with Sketch.

Featured News

PLY PlaySide to take gamers back to Westeros with new PC title
right-arrow Created with Sketch.
TVN CSIRO backs Tivan's downstream tech for WA vanadium concentrate
right-arrow Created with Sketch.
VMS Venture hits 1,839 TREO at Jupiter in WA with best intersection to date
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.
DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.

(20min delay)
Last
6.9¢ 		Change
-0.001(1.43%) 		Mkt cap ! $512.3M
Open High Low Value Volume
7.0¢ 7.1¢ 6.9¢ $377.8K 5.408M

Buyers (Bids)

No. Vol. Price($)
23 3142251 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 1313337 12
View Market Depth
Last trade - 13.20pm 27/05/2024 (20 minute delay) ?
Last
7.0¢ 		  Change
-0.001 ( 0.28 %)
Open High Low Volume
7.1¢ 7.1¢ 6.9¢ 3467619
Last updated 13.32pm 27/05/2024 ?
IMU (ASX) Chart

Top Stories

Elsight's Halo shines on take off in the Land of the Rising Sun

Elsight’s Halo (ASX:ELS) has been selected by ACSL, Japan’s largest drone manufacturer, as the Beyond Vision Line Of Sight (BVLOS) Communications platform for its drones.Elsight announced today that ACSL had chosen Halo, in conjunction with new Japanese regional pa...
Historical prospects impress Solstice, with 25% copper and significant anomaly Solstice Minerals Ltd has picked up impressive base metal mineralisation from historical analysis and sampling at two new prospects in WA.
Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans Telix Pharmaceuticals has submitted a new drug application to the United States Food and Drug Administration for TLX007-CDx,
High-grade gossans with VMS potential impress Dreadnought in WA Dreadnought Resources Ltd has identified gossans with high grades of precious and base metals at the Tiger prospect in WA.
Week 21 Wrap: NVIDIA's profits are up 600% – but this time, the market didn't really care Not long now, and we'll be at the halfway point of the year. And while it may not feel much different, a lot would have changed.

Featured News

DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.
TLM Talisman expands Rip n Tear with lead grading 7.4% and silver at 59.2g/t in NSW
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
TVN CSIRO backs Tivan's downstream tech for WA vanadium concentrate
right-arrow Created with Sketch.
NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.